RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. (IST:RTALB)

Market Cap	1.82B +17.4%
Revenue (ttm)	239.56M +15.4%
Net Income	881.18M +1,188.8%
EPS	1.76 +1,189.2%
Shares Out	500.00M
PE Ratio	2.07
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,272,371
Average Volume	37,970,625
Open	4.000
Previous Close	3.640
Day's Range	4.000 - 4.000
52-Week Range	2.590 - 4.800
Beta	0.34
RSI	52.91
Earnings Date	May 11, 2026

About IST:RTALB

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers real-time PCR kits, nucleic acid extraction kits, microbiology media, microbiology stains, and rapid tests; standards and reference materials, and membrane filters; chemicals and reactives, membrane filters, microbiology gas generators, and other consumables; and instruments and consumables. RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Tic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1996
• Employees: 81
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: RTALB

Financial Performance

In 2025, IST:RTALB's revenue was 239.56 million, an increase of 15.41% compared to the previous year's 207.58 million. Earnings were 881.18 million, an increase of 1188.81%.